Literature DB >> 7259240

Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.

M R Pittelkow, H O Perry, S A Muller, W Z Maughan, P C O'Brien.   

Abstract

For many years, crude coal tar has been used for the treatment of psoriasis. The possible carcinogenic effect of crude coal tar and ultraviolet (UV) radiation (Goeckerman regimen), considered individually or in combination, has been of some concern to physicians. A 25-year follow-up study was completed on 280 patients with psoriasis who were hospitalized and treated with crude coal tar and UV radiation at the Mayo Clinic, Rochester, Minn, during the years 1950 through 1954. The results of this study suggest that the incidence of skin cancer is not appreciably increased above the expected incidence for the general population when patients are treated with coal tar ointments. It seems that the Goeckerman regimen (topical crude coal tar combined with UV radiation) can be used with minimal risk for skin cancer in the treatment of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259240

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

1.  Multiple pigmented papular basal cell carcinomas: a new pattern of industrial tar induced skin tumours.

Authors:  L G Millard
Journal:  Br J Ind Med       Date:  1986-02

2.  Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Authors:  Allison K Ehrlich; Nancy I Kerkvliet
Journal:  Curr Opin Toxicol       Date:  2017-02-01

3.  Coal tar therapy. Is it carcinogenic?

Authors:  F J van Schooten; R Godschalk
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

4.  Current treatment of psoriasis.

Authors:  J D Epstein
Journal:  Can Fam Physician       Date:  1987-10       Impact factor: 3.275

Review 5.  Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy.

Authors:  Madison Dennis; Tina Bhutani; John Koo; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2011-08-24       Impact factor: 3.359

Review 6.  Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.

Authors:  Shamir Geller; Haoming Xu; Mark Lebwohl; Beatrice Nardone; Mario E Lacouture; Meenal Kheterpal
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

Review 7.  Recognition and treatment of psoriasis. Special considerations in elderly patients.

Authors:  C Bonifati; M Carducci; A Mussi; L D'Auria; F Ameglio
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

Review 8.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

9.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

10.  The Goeckerman regimen for the treatment of moderate to severe psoriasis.

Authors:  Rishu Gupta; Maya Debbaneh; Daniel Butler; Monica Huynh; Ethan Levin; Argentina Leon; John Koo; Wilson Liao
Journal:  J Vis Exp       Date:  2013-07-11       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.